(C) Common Dreams
This story was originally published by Common Dreams and is unaltered.
. . . . . . . . . .
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests [1]
['Annika Kim Constantino']
Date: 2024-03-27
The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close to $1,000 per month for the injection in the U.S. before insurance, a study released Wednesday suggests.
The study, from researchers at Yale University, King's College Hospital in London and the nonprofit Doctors Without Borders, raises more questions about the hefty price tag of the top-selling diabetes treatment and similar drugs for weight loss, which are all part of a new class of treatments called GLP-1s.
Demand for those medicines has soared over the last year, even as more insurers drop them from their plans due to cost, leaving some patients unable to afford the drugs.
The study also comes after years of political pressure on Novo Nordisk and other drugmakers to slash high costs of diabetes care, especially insulin.
Ozempic can generally be produced for less than various forms of insulin, according to the study published in JAMA Network Open.
[END]
---
[1] Url:
https://www.cnbc.com/2024/03/27/novo-nordisk-ozempic-can-be-made-for-less-than-5-a-month-study.html
Published and (C) by Common Dreams
Content appears here under this condition or license: Creative Commons CC BY-NC-ND 3.0..
via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/commondreams/
